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ABSTRACT 
Birth is initiated by a programmed inflammatory response of the placenta and amniotic 
fluid carried out by maternal and fetal signals, between 37-42 weeks gestation for 
human females and 320-340 days gestation for mares. When the inflammatory 
response occurs prematurely, pre-term birth is initiated. Pre-term birth is most 
commonly associated with a maternal infection that consequently leads to infection of 
the placenta and amniotic fluid; however, the terms of infection are unclear, as 
microbiota has been discovered in placental membranes and amniotic fluid of healthy 
pregnancies. The objective of this study is to challenge the sterile womb hypothesis and 
investigate the relationship between microbiota and negative pregnancy outcomes, 
specifically pre-term birth. Blood, oral, fecal, uterine, and vaginal samples were 
collected from 58 postparturient mares by attending veterinarians at Hagyard Equine 
Institute in Lexington, KY, within 24-36 hours of foaling and before uterine 
lavage/infusion. Expected due date and date of delivery was noted for birth 
categorization as either pre-term or full-term. A foal is considered pre-term if born prior 
to 320 days gestation. Microbiota samples were prepared on sterile nasopharyngeal 
swabs, which were then used for 16S rRNA gene sequencing on Illumina MiSeq. 
Sequencing output was analyzed using QIIME 1.9 on VirtualBox. The abundance of 
Fusobacteria, across all samples, in mares that delivered pre-term (PT) was 2-fold higher 
than those who delivered full-term (FT). Moreover, Fusobacteria comprised 15% of PT 
vaginal samples in comparison to 4.9% FT vaginal. Nearly identical ratios are observed in 
uterine samples of PT and FT deliveries (15.5% and 4.4% respectively). Fusobacteria is a 
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common, nonpathogenic microbe of the oral cavity but can cause periodontitis in the 
case of overgrowth. Fusobacteria can also lead to negative pregnancy outcomes if 
transferred hematogenously through the placenta. However, this is not the case in the 
PT deliveries of this study, as Fusobacteria did not comprise even one percent of both 
oral and blood samples. On the other hand, Fusobacteria has been reported in the 
vaginal microbiome of negative reproductive health and pregnancy outcomes, such as 
bacterial vaginosis and pre-term births. These results support the hypothesis that 
vaginal microbiota may vertically ascend through the cervix and into the uterine cavity 
to proliferate and colonize. We suggest a cross talk occurring between vaginal 
microbiota and the uterine environment. Whether this interaction always leads to 
negative outcomes is unclear, although the inflammation of the placenta and amniotic 
fluid in response to such microbes may be a consequence of their uncontrolled 
proliferation.  
 
Key words: microbiome, microbiota, vaginal, uterus, pre-term, birth, reproduction, 
equine 
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CHAPTER 1 
INTRODUCTION 
 
Up until the early 2000s, health and disease had been primarily attributed to 
two major factors: genetics and environment. Understanding the human genome has 
and continues to be a crucial part of research science in discovering complex 
mechanisms that drive each system and how alterations to the genome, whether by 
random mutation or epigenetically driven, can lead to disease development. There 
was, however, an important component of the human body that was being ignored: 
the microbiota. Though its presence was known, not much thought had been given to 
the nonpathogenic microorganisms that inhabit every living animal.  
Symbiotic relationships have been a driving force of evolution and species 
survival. Such relationships, in which all of the organisms involved benefit, is said to be 
mutualistic. The Oxpecker bird lands on rhinos or zebras and eats parasites living on 
their skin, in exchange for safe transportation. Bees aid in pollination of flowers when 
collecting nectar, from which they make food, leaving behind pollen from other 
flowers. However, perhaps the most complex and least understood of these is 
between the mammalian body and its “normal flora”, which live on and inside the 
body, and perform a variety of functions beneficial to mammals.  These taxa of 
bacteria are a variety of different phyla, an estimated 10-100 trillion microbial cells 
that inhabit mucosal and epithelial areas of the body such as the gastrointestinal (GI) 
tract, skin, mouth, vagina, urogenital tract, and respiratory tract. These resident, 
commensal microbes are termed microbiota [1].  
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In 2001, Joshua Lederburg coined the term ‘microbiome’, to describe the 
genetic catalog of communal microbiota and its ecological relationship with the host 
[2]. Included in its definition are bacteria, yeast, fungi, and viruses, though this thesis 
will focus solely on bacterial microbiota [1, 2]. Since the launch of the National 
Institute of Health’s (NIH) Human Microbiome Project (HMP) in 2008, research 
scientists have uncovered a plethora of evidence in association with the role of 
microbiota in health and disease. It has become clear that when microbiota are 
undisturbed in their desired niche, they perform beneficial functions for the host in 
exchange for nutrients and other components for survival. However, when these 
populations are disturbed and no longer in homeostasis with the host, overall health is 
often compromised.  
In 2008, the NIH HMP reported approximate distributions of bacterial 
microbiota throughout the body as: 29% GI tract, 26% oral, 21% skin, 14% airways, 9% 
urogenital regions, 1% blood, and 0% in the eyes [2]. It was also reported by the 
MetaHit Consortium that the gut microbiome alone contains approximately 3.3 million 
nonredundant genes [1]. The human genome consists of an estimated 22,000 genes; 
therefore, this finding revealed that our own cells are dramatically outnumbered by 
the microbial cells on and inside of us, an estimate of a 10:1 microbe-host cell ratio [1, 
3]. This means that for every single cell belonging to the host, there are 10 microbial 
cells, suggesting that we are actually 10% human and 90% microbial ecosystem.  Since 
the microbial cells outnumber the host cells, humans must have evolved mechanisms 
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for dealing with such large populations of microbes to prevent their destruction by the 
immune system [4].  
Several evolutionary theories have developed in regard to host-microbiota 
symbiosis. Foster et al. describes the host microbiome as an, ‘ecosystem on a leash,’ 
meaning that humans have developed mechanisms that allow them to keep 
microbiota under favorable conditions while keeping proliferation rates controlled [4]. 
First, the review discusses the problem with a diverse microbiota: natural selection will 
favor microbes that proliferate at rapid rates and will select against those that 
replicate slowly, regardless of the benefit that the slower-growing microbe may bring 
to the host. This suggests that, from an evolutionary theory perspective, microbes that 
invest in their own reproductive fitness outcompete those that do not. Therefore, it 
cannot rightfully be assumed that the host and microbial communities work together 
to benefit one another; rather, it is more reasonable to infer that the outcome of our 
health is dependent on the microbes that survive under selective pressures [4]. This 
may explain why particular microbiome characterizations correlate with particular 
disease states. Even with this information, it is still observed that the microbiota 
predominantly contains beneficial microbes, giving rise to the theory that the host 
possesses monitoring and targeting mechanisms as a means of providing its own 
selective pressure [4]. Given these two opposing theories, it remains unclear whether 
natural selection or host monitoring is the ultimate decision maker in choosing which 
microbes survive. 
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 Throughout this thesis, the following topics will be discussed in regard to 
microbiota: functions, niche preferences, and interactions with the host. Outlined 
interactions with the host will primarily focus on those of the female reproductive 
tract, although gut microbiota functions are briefly reviewed as these microbes have 
proven to play a substantial role in overall health. Though much has been discovered 
about the microbiome’s influence on human health, we have merely scratched the 
surface of the topic. Considering the ratio of microbiome DNA to host DNA, it is 
reasonable to suggest that until we understand the microbiome, we cannot fully 
understand the human genome [1].  
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CHAPTER 2 
BACKGROUND 
 
2.1 The Gut Microbiome 
2.1.1 Overview  
 More than a quarter of our resident microbiome resides within the 
gastrointestinal tract, which is a key reason for why this particular area has been given 
a lot of attention in microbiome research. Gut microbes are known to aid in nutrient 
absorption and modulation of the immune response. Within the past decade, studies 
have suggested these microbes are responsible for the overall health of an individual, 
proposing new potential interactions with every system in the body. In support of this, 
it has been demonstrated that when the continual flux of gut microbiota is disrupted, 
disease susceptibility increases. These diseases range from cancers, autoimmune 
disorders, cardiovascular diseases, metabolic syndromes, to endocrine disorders. 
Although this study focuses on microbe-female reproductive interactions, it is 
important to note and appreciate the diversity of the functions of the gut microbiota, 
as it plays a significant role on reproductive health.  
2.1.2 Nutrient Absorption and Immunomodulation  
 The large intestine (colon) is an ideal environment for anaerobes, both obligate 
and facultative [4]. Bacteria that reside here predominantly undergo anaerobic 
respiration and carry out fermentation, which is useful in the breakdown of 
indigestible carbohydrates, such as cellulose and pectin, into short fatty-acid chains [5]. 
These short fatty-acid chains can be metabolized as precursors for cholesterol 
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synthesis, utilized in the liver for gluconeogenesis, lipogenesis, and protein synthesis, 
and contribute to 3-9% of overall energy requirements of humans. Few microbial 
communities can be found in the stomach and small intestine due to the bactericidal 
activity of gastric acid [5]. However, as of 2009, the presence of Lactobacillus, 
Veilonella, and Helicobacter has been reported in the stomach at approximately 101 
cells/gram of stomach contents [6]. Moving along the GI tract, abundance and diversity 
increase greatly. The duodenum contains approximately 103 cells/gram, the jejunum 
104 cells/gram, and the ileum 107 cells/gram. In addition, the colon contains an 
estimated 1012 cells/gram. Although the composition and abundance of gut microbes 
fluctuates daily, there are certain phyla that remain fairly consistent. Bacteroidetes 
and Firmicutes are the predominant phyla (particularly in the large intestine), with 
smaller proportions of Proteobacteria, Actinobacteria, Cyanobacteria, Fusobacteria, 
Tenericutes, and Verrucomicrobia [6, 7]. When observing beyond the phylum level, 
variation in microbial communities increases. It is speculated that due to functional 
redundancy, different microbes capable of performing the same functions across phyla 
allow for variation on the genus and species level [7].  
 Bacterial populations differ greatly between mucosal/epithelial layers and the 
intestinal lumen. For example, commonly reported microbiota present in the mucosal 
and epithelial areas includes Clostridium, Lactobacillus, and Enterococcus, whereas 
typical microbiota of the intestinal lumen includes Bacteroides, Bifidobacterium, 
Streptococcus, Enterobacteriaceae, Enterococcus, Clostridium, Lactobacillus, and 
Ruminococcus [6]. Approximately 1-3 genera are shared between these areas. 
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Variation between intestinal environments is primarily due to the differing functions of 
the stomach, small intestine, and colon, as well as their divergent structures, which 
corresponds to the metabolic requirements of the residing microbiota [6].   
 Factors such as diet, antibiotic use, infection, sexual contact, and stress can 
lead to alterations of gut microbiota [5-7]. However, there are particular circumstances 
in which some factors do not have a significant affect. For instance, diet does not seem 
to influence composition or abundance of microbiota in pregnant women. 
Proteobacteria and Actinobacteria have been demonstrated to increase in the gut 
microbiome of pregnant women despite decrease in overall richness, which is defined 
as the number of different species in an ecological community [5]. During pregnancy, 
estrogen levels remain high in contrast to non-pregnant women, in which estrogen 
and progesterone levels peak then decrease at different periods of the menstrual 
cycle. This suggests that hormones may play a role in the regulation of microbial 
communities, or conversely. Furthermore, particular situations such as pregnancy, may 
lead to hormone interactions with microbes that outcompete that of dietary effects. 
Pregnancy, however, is the only circumstance known to date in which reduced dietary 
effects on gut microbiota composition have been observed. Several studies have 
produced a germ-free mouse model without metabolic defects that become obese 
after transfer of microbiota from obese mice [8-10]. Furthermore, when gut microbes 
of lean mice are transferred to obese mice, obesity is resolved, thus supporting the 
hypothesis that gut microbiota plays a role in maintaining a healthy body weight unless 
present in the wrong proportions. This means that certain gut microbes have differing 
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functions that affect the host inversely. For instance, Bacteroidetes are more efficient 
in lipid metabolism, whereas Firmicutes are not. A higher abundance of Firmicutes in 
ratio to Bacteroidetes has been associated with increased fat deposition and body 
weight, placing greater importance on proper nutrition that appeals to the individual’s 
GI microbiota that inclines an individual toward a healthy weight [8, 9]. 
 Commensal microbes are able to inhabit their host without causing disease 
pathogenesis because they are recognized by the host as nonthreatening, meaning the 
host has tolerance for microbiota. Gut microbiota, in particular, are able to enhance 
the innate immune response. Intestinal epithelial cells (IECs) and Paneth cells provide a 
barrier function by physically confining commensal and pathogenic microbes to the 
intestinal lumen [11]. Paneth cells prodyce additional immune responses by secretion 
of antimicrobial peptides (AMPs) and expression of nucleotide-binding oligomerization 
domain-containing protein 2 (NOD2), which initiates innate immune signaling in 
response to the cytosolic peptidoglycan fragment, muramyl dipeptide (MDP). 
Microbiota in the intestinal lumen can upregulate Paneth cell immune responses by 
activating Toll-like receptors (TLRs) on IECs and Paneth cells, inducing Reg3γ 
expression. Reg3γ is an islet-derived C-type lectin that is bactericidal against Gram-
positive bacteria [11]. Furthermore, innate lymphoid cells enhance this function of gut 
microbiota through the production of the cytokine interleukin-22 (IL-22). IL-22 
promotes IEC growth and Reg3γ expression. Additionally, microbiota-derived MDP can 
activate NOD2 on Paneth cells, which stimulates production of a subset of AMPs called 
defensins. Defensins function in host defense with activity against bacteria, fungi, and 
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many viruses [11]. Additional immune functions of gut microbiota include 
development of Foxp3+ T regulatory cells, stimulation of secretory IgA from mucosal 
plasma cells, shaping of gut associated lymphoid tissue (GALT), and stimulation of the 
immunomodulatory action of macrophages of the intestinal lamina propria [7]. 
2.1.3 Dysbiosis and Disease  
 Gut dysbiosis, a complete shift in whole populations of gut microbiota, has 
been associated with several diseases and conditions, including atherosclerosis, 
hypertension, obesity, colitis, Alzheimer’s disease, and even psychiatric disorders [12-
16]. Dysbiosis of the gut microbiota can be influenced by several factors, such as the 
use of broad-spectrum antibiotics, disease in which inflammation of the GI tract 
occurs, and poor nutrition [5, 14]. Interestingly, gut dysbiosis has been associated with 
disorders that alter reproductive functionality; the most commonly associated 
reproductive disorder being polycystic ovary syndrome (PCOS) [5]. As of 2016, the 
estimated prevalence of women diagnosed with PCOS was approximately 15% of 
women worldwide, making it the most common endocrine disorder for females [17]. 
This disorder is characterized by hyperandrogenemia (excess androgen production), 
obesity, insulin resistance, irregular menstrual cycles, and ovaries that develop 
multiple cysts. These cysts are categorized as either physiological (follicular and luteal 
cysts) or pathological (ovarian tumors) [18, 19]. Association between gut dysbiosis and 
PCOS suggests that a hormone imbalance may alter GI microbiota composition, or that 
the GI microbiota composition may cause a hormone imbalance.   
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 Physiological cysts are solid or fluid-filled pockets in the ovary that typically 
become inflamed. Formation of cysts is most commonly a consequence of a follicle’s 
failure to reach maturity, resulting in the inability to release an oocyte- termed 
‘anovulation’ [18]. It is common for a physiological ovarian cyst to occasionally 
develop, but it is usually not life-threatening and resolves on its own. However, in 
women with PCOS, physiological cysts form with nearly every menstrual cycle, halting 
menstrual flow from occurring. This also makes it difficult, or impossible in some cases, 
for the female to reproduce successfully. A frequently observed secondary outcome of 
PCOS is endometriosis, which is the abnormal growth of endometrial cells outside of 
the uterus, most commonly on other organs within the pelvis [18]. Endometriosis can 
be life-threatening and dramatically decreases the individual’s fertility. In both cases, it 
has been shown that the gut microbiota becomes altered, though it is unclear as to 
which circumstance is the cause and which is the effect [17, 19].  
  Gut microbiome alterations have been investigated in PCOS mouse models, 
which is achieved by administration of letrozole. Letrozole is a nonsteroidal aromatase 
inhibitor, preventing cleavage of testosterone into estrone; therefore, estradiol levels 
are reduced [17]. Kelley et al. reported that letrozole treatment resulted in decreased 
species abundance and decreased alpha and beta diversity (diversity within a sample 
and between sample types, respectively). They also observed that after one week of 
letrozole treatment, a shift in the gut microbiome occurs, largely effecting 
Bacteroidetes and Firmicutes. Given these results, it was concluded that steroid 
hormones might regulate the gut microbiome as aromatase activity has not yet been 
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described in bacteria. Since it was an aromatase inhibitor that was used, it was 
determined that PCOS leads to gut dysbiosis and not the other way around. Since this 
study was the first to demonstrate a hormone interaction with gut microbiota by 
manipulating endogenous testosterone, further studies are required to support or 
refute the conclusion that PCOS is the cause and gut dysbiosis is the effect [17]. An 
alternative explanation to consider is that either circumstance can occur first, leading 
to the other in a bidirectional manner.  
 In a study conducted by Lindheim et al., gut microbiome composition and 
barrier functions of the gut in 24 PCOS-diagnosed females with reproductive and 
metabolic defects were compared to that of 19 healthy women [19]. They discovered 
that the phyla Tenericutes and Bacteroidetes were significantly lower in stool samples 
of PCOS subjects and were associated with reproductive defects. Furthermore, their 
results revealed that, in some cases, gut barrier dysfunction and endotoxemia 
contribute to metabolic defects observed in PCOS patients. Similarly to the study by 
Kelly et al., they were unable to determine if gut dysbiosis lead to PCOS development 
or vice versa [19]. It may be useful to induce gut dysbiosis in a mouse model and 
monitor for any reproductive abnormalities that result. In addition, if PCOS 
development is not observed in these mice with gut dysbiosis, letrozole-induction of 
PCOS could be administered to observe how an already altered gut microbiome 
influences the severity of PCOS reproductive and metabolic defects.  
 In conclusion, the resident microbes of the GI tract play key roles in 
carbohydrate and lipid metabolism, nutrient absorption, immunomodulation, and 
12 
maintenance of the overall health of the body. It appears that in order for the health 
of the body to be maintained, the gut microbiota composition must be undisturbed. 
When composition is altered by any factor previously mentioned, overall health is 
compromised and disease susceptibility increases. When studying the microbiota 
composition of a particular body site, it is important to consider the gut microbiome as 
well, as it may have influence over the site of interest.  
2.2 Organization and Functions of the Female Reproductive Tract 
2.2.1 Overview 
 The female reproductive system is the organization of both internal sex organs 
and external genitalia that function in concert with one another. The progression of 
follicular development to ovulation and menstruation, or pregnancy, is generally well 
understood; however, little is known about how the microbiome influences pregnancy 
outcomes. The lack of knowledge is primarily as to whether the amnion, defined as the 
innermost membrane within the uterus that encloses the embryo/fetus, is truly a 
sterile environment. If the amnion is not sterile, what consequences does this bear on 
female reproductive health? More specifically, are pregnancy outcomes affected by 
the resident microbiota of the host?  
2.2.2 Follicular Development: Humans versus Mares 
 The ovaries carry out two primary functions: gametogenesis and 
steroidogenesis [20, 21]. Gametogenesis is defined as the production of gametes, 
which is termed oogenesis for females. The term oocyte refers to a gamete in 
development and ovum refers to a mature gamete [20]. Steroidogenesis executed by 
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the ovary is the production of the appropriate sex steroid hormones, estrogen and 
progesterone [22]. This process occurs in both theca and granulosa cells of the ovary, 
which will be discussed later in this section. It is important to note that other 
hormones, such as luteinizing hormone (LH) and follicle-stimulating hormone (FSH), 
are involved in oogenesis; however, it is the pituitary gland that produces and secretes 
these hormones [21, 22].  
2.2.2.1 Folliculogenesis in Human Females 
 Ovaries contain structures called follicles, which house the oocyte and undergo 
extensive maturation steps influenced by both sex steroid hormones and 
gonadotropins until the oocyte develops into an ovum through a process known as 
folliculogenesis [21]. Follicle production occurs early in fetal development, as mitotic 
divisions increase the number of oogonia, later giving rise to primary oocytes. These 
initial follicles are termed primordial follicles and are present at birth where they will 
remain in a state of arrest until puberty [21]. There are three developmental states of 
ovarian follicles: primordial, growing (further classified into primary and secondary), 
and mature/Graafian [20]. The size of the follicle is typically indicative of its 
developmental state; however, the change in particular structures associated with the 
follicle is key to its identification [20, 21].  
 Primordial follicle assembly in the ovaries is not dependent on gonadotropin 
stimulation, as these follicles are developing during early fetal life, around the third 
month of development [21]. Once the ovary has reached maturity, primordial follicles 
are stored in the stroma of the cortex, beneath the tunica albuginea, which is the 
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external connective tissue covering the ovaries [20]. Structural changes become 
apparent once a primordial follicle becomes a primary follicle, which is identified as 
such when the flattened follicular cells surrounding the growing oocyte proliferate and 
become cuboidal. It is at this stage that the oocyte’s protective barrier, termed the 
zona pellucida, is formed between the oocyte and adjacent follicle cells. The zona 
pellucida is an extracellular covering abundant in sulfated acidic glycoproteins (labeled 
ZP-1, ZP-2, and ZP-3), which function in spermatozoa binding and induction of the 
acrosome reaction, characterized by the release of enzymes to allow a single sperm 
cell to penetrate the zona pellucida [20]. The enzymes released in this reaction are 
primarily hyaluronidases, which act by catalyzing the degradation of hyaluronan- a 
chemical compound found at high concentrations in the extracellular matrix covering a 
mature ovum [20, 21].  
 The cells surrounding the primary oocyte rapidly proliferate into a stratified 
epithelium, termed the stratum granulosa [20]. Cells in the stratum granulosa become 
granulosa cells; these are the cells in which progesterone production occurs [22]. Two 
types of receptors can be found on the granulosa cell: the LH receptor and the FSH 
receptor, although FSH receptors are greater in abundance due to continual growth of 
the follicle [22, 23]. Due to proliferation of granluosa cells, a connective tissue layer 
forms from stromal cells that proximately enclose the follicle. This layer is termed the 
theca folliculi, which will further differentiate into the theca interna and theca externa 
[20]. Cells within the theca layers are termed theca cells and those within the theca 
interna possess a large number of LH receptors [23]. The external layer serves as an 
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outer layer of connective tissue barrier. Until this point, the follicle has been avascular; 
however, it is within theca cells that blood vessels begin to appear, which will later 
serve as a transportation route for the appropriate hormones. At this stage in 
development, the follicle is now classified as a secondary follicle [20].  
 Progesterone production also occurs in theca cells and is driven by conversion 
of ATP to cyclic AMP (cAMP) [22]. The secondary follicle continues to grow in size due 
to stimulation by FSH, growth factors, and recruitment of calcium ions until an antrum 
forms on one side of the oocyte. Antrum formation is the key characteristic that now 
classifies the follicle as a tertiary follicle [20]. Once the antrum becomes a fluid-filled 
cavity rich with hyaluronanic acid, termed follicular fluid, the follicle is designated as 
mature/Graafian. Upon initiation of ovulation, the Graafian follicle will rupture and 
release the oocyte through the oviduct (fallopian tube) by the fimbriae and into the 
uterus for fertilization [20]. The ruptured follicle will collapse into deep folds, giving 
rise to the corpus luteum, also termed the luteal gland [20, 22]. The theca interna and 
granulosa cells become luteal cells by luteinization, which causes the cells to 
dramatically increase in size and fill with lipid droplets [23]. Lutein cells within the 
corpus luteum establish a highly vascularized network derived from the theca interna 
cells. This vasculature will serve as a hormone transportation route for preparing the 
endometrium for implantation in the event of fertilization [23]. In the absence of 
fertilization and subsequent human chorionic gonadotropin (hCG), the corpus luteum 
will degenerate approximately 10-12 days after ovulation [20]. As the corpus luteum 
regresses, menstrual flow begins, which is a 3-7 day process. Menstrual flow is the 
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partial shedding of the endometrium’s stratum functionale layer (the portion that 
becomes thicker throughout the ovulatory cycle) and bleeding as a result of 
destruction of the mucosal vessels [20, 21]. 
 As previously mentioned, gonadotropins released from the anterior pituitary 
drive the follicles in both the growth/follicular phase and the luteal phase (Figure B1). 
During the follicular phase, FSH carries out two main functions: follicle growth and 
stimulation of estradiol production [22]. To begin this process, FSH will bind to FSH 
receptors on granulosa cells. Activation of FSH receptors causes rapid proliferation of 
granulosa cells for follicle growth. These new granulosa cells will express the enzyme 
aromatase, which is responsible for cleaving testosterone into estradiol. The source of 
testosterone comes from theca cells [22, 23]. Upon stimulation of LH receptors by LH, 
LDL will enter the cell and be used to synthesize pregnenolone followed by 
progesterone. Progesterone is chiefly responsible for preparing the internal sex organs 
for pregnancy, specifically the uterus, by stimulating secretory changes in the 
endometrium [22]. Progesterone can also be converted to 17-OH-Progesterone, which 
is then converted to androstenedione, the precursor to testosterone. 
Androstenedione can be readily cleaved by either aromatase or 17β-hydroxysteroid 
dehydrogenase (HSD). Cleavage by aromatase produces conversion to estrone, then to 
estradiol by 17β-HSD [22, 23]. On the other hand, cleavage of androstenedione by 
17β-HSD causes conversion to testosterone, which will translocate to granulosa cells 
through the basement membrane to be cleaved by aromatase into estradiol. Estradiol 
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plays a key role in sexual maturation, meaning it is responsible for development of 
female sex characteristics such as breast development, and follicular maturation [22]. 
Aside from aiding in estradiol production, LH also plays a role in ovulation and 
choosing the dominant mature follicle [23]. During the midpoint of ovulation, a surge 
of LH will migrate to the follicle that has the most LH receptors expressed on the 
surface of theca cells, ultimately choosing it to achieve full maturation [24]. This surge 
of LH will signal luteinization of granulosa and theca interna cells, which will transition 
the follicle from the follicular phase to luteal. The luteal phase starts at day 14 of the 
menstrual cycle when ovulation is complete. It is during this phase that estrogen levels 
decrease sharply and progesterone dominates. This increase in progesterone is what 
leads to a thickening of the stratum functionale. The source of progesterone comes 
from granulosa lutein and theca lutein cells of the corpus luteum [24]. 
 
 
 
 
 
 
 
 
 
Figure B1. The Human Female Menstrual Cycle. Divided into two phases: follicular and luteal. The 
follicular phase occurs during days 4-14 and involves the maturation of an ovarian follicle until oocyte 
release (ovulation). During the follicular phase, estrogen and FSH are the dominant hormones. The 
luteal phase (days 12-14), is characterized by a surge of LH and signals the final maturation into a 
Graafian follicle and release of oocyte at ovulation. The corpus luteum develops and primarily produces 
progesterone to thicken the endometrium for possible implantation. (From: Encyclopedia Brittanica, Inc. 
2008). Source(s): Clayton, S. G. Menstruation (2018), https://www.britannica.com/science/menstruation  
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It is important to note that during follicular development, several follicles are 
developing simultaneously within the ovary. It is the surge of LH at mid-ovulation that 
chooses which follicle will release its mature oocyte [24]. The remaining follicles will 
undergo atresia, a process mediated by apoptosis of granulosa cells [20]. Primordial 
and primary atretic follicles will shrink and eventually disappear after repeated 
apoptosis. Large, growing atretic follicles degenerate in the same fashion; however, if 
they contain a mature oocyte, the oocyte itself will be delayed in its destruction as it is 
no longer sensitive to atresia stimuli of the follicle. Once menstruation has reached 
completion, primordial follicles will repeat the process of follicular development. 
Unlike males, females have a predetermined gamete quantity, approximately 400 
oocytes [20]. When this reserve is depleted, the female will no longer ovulate and 
menstruate, marking the stage of menopause [25].   
2.2.2.2 Folliculogenesis in Mares 
  Like human females, follicular and oocyte development occurs in early fetal life 
and is independent of gonadotropin stimulation [26]. During this period, at 
approximately 70 days of gestation, primordial germ cells proliferate and meiotically 
divide until around 150 days of gestation, when they are arrested in prophase I as 
primary oocytes. At this time, oocytes are developing into primordial follicles, which 
will occur throughout fetal life so that thousands of follicles are present within the 
ovaries upon birth. The period in which primary oocytes proliferate, divide, arrest, and 
subsequently develop into primordial follicles is termed the preantral stage [26].  
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 For mares, there are four classifications of follicular development: primordial, 
primary, secondary, and antral [26]. Primordial, primary, and secondary follicles 
develop during the preantral stage. Maturation of a primordial follicle to a primary 
follicle is initiated by the proliferation of somatic cells surrounding the primordial 
follicles, similar to when flattened follicular cells surrounding primordial follicles, in 
humans, proliferate and become cuboidal, marking the transition of the follicles from 
primordial to primary. Proliferation of surrounding somatic cells occurs during post-
natal life, stimulated either by atresia or a surge of LH. Classification of primary and 
secondary follicles is solely based on size, with a 0.1mm diameter categorized as 
primary and 0.2mm classified as secondary [26].  
 Developing follicles enter the antral stage upon formation of an antrum, which 
occurs when the follicles are approximately 0.3mm in diameter [27]. Once antral 
follicles reach a diameter of 2mm, their growth and the subsequent selection of a 
dominant follicle is determined through follicular waves, which are under the systemic 
control of gonadotropins and the local control of insulin-like growth factor-1 (IGF-1), 
sex steroid hormones (estrogen and progesterone), inhibins, activins, and vascular 
endothelial growth factor (VEGF) [26]. Follicular waves are defined as the simultaneous 
development of several growing follicles at a common growth rate, which is typically 2-
3 mm in diameter per day and occurs during estrus. Follicular waves are categorized as 
either major or minor waves [27]. Minor waves are characterized by smaller, 
subordinate follicles (< 30mm diameter) in the absence of a dominant follicle. Minor 
waves occur outside of breeding season to ensure the mare undergoes anovulatory 
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estrous cycles [26, 27]. Major waves produce a dominant ovulatory follicle, with 1-2 
waves (primary and secondary) occurring around the middle of the estrous cycle [26]. 
IGF-1 initiates deviation of the dominant follicle by upregulating other growth factors, 
which in turn will lead to increased diameter of the follicle that has the most receptors 
for the growth factors, meaning it binds more ligand than the other follicles and will, 
therefore, become the dominant ovulatory follicle. A unique characteristic of the mare 
estrous cycle is that ovulation occurs at high levels of progesterone [26]. This differs 
from that of human female ovulation, which occurs in the presence of high estrogen 
concentrations.   
2.2.3 The Estrous Cycle Varies Between Mammals 
 In humans, the process of follicular development, ovulation, and subsequent 
shedding is termed menstruation. In other mammals, such as mares, baboons, and 
mice, this cycle is termed the estrous cycle [28]. As this study involves reproduction in 
mares, it is important to understand the differences in cycles between humans and 
horses, and a commonly used laboratory model- the CD1 female mouse. For most 
mammals, such as the mouse and the baboon, there are four stages of the estrous 
cycle, from primary follicle development to shedding of the endometrial mucosal layer: 
metestrus, diestrus, proestrus, and estrus [28].  
In mice, metestrus defines the period in which the primary follicle is 
undergoing changes to become a secondary follicle and is influenced by a rise in 
progesterone levels. During diestrus, the primary follicle has matured into the 
secondary follicle and progesterone levels decrease as estrogen production increases. 
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Proestrus is the complete maturation into a Graafian follicle, as estrogen levels sharply 
decrease and progesterone dominates for a brief period. It is at this stage that 
ovulation occurs, which occurs on day four or five [28]. Upon absence of fertilization of 
the ova, the corpus luteum regresses and the lining of the endometrium begins to 
shed, beginning the final stage of estrus. Estrus is characterized by a sharp increase in 
estrogen during the dark cycle (night time) and a return to basal levels in the morning 
as estrus reaches completion. It is important to distinguish between estrous cycle and 
estrus; estrous cycle refers to the complete menstrual cycle, whereas estrus refers to 
menstruation (endometrial mucosal layer shedding). In humans, menstruation 
normally lasts 3-7 days; however, this is quite short-lived for a mouse, as shedding only 
lasts for approximately 12-hours [28]. Defining menstruation changes when discussing 
the estrous cycle of the mare. 
 The mare is described as a polyestrous mammal, meaning it undergoes 
ovulatory estrous cycles seasonally [27]. The mare experiences ovulatory estrous 
cycles during a particular season in contrast to monthly repetition for humans and 
weekly repetitions for mice. Seasonal breeding is a selective pressure that acts to 
prevent the mare from delivering during harsh, cold weather [29]. Ovulatory estrous 
cycles occur during the months of May to October, lasting approximately 22 days each, 
with 5-7 days of this period being in estrus, during the spring and summer breeding 
season. A feature of the mare’s estrous cycle that makes it unique from the human 
and mouse is that it is positively phototropic, meaning that it is directly initiated and 
controlled by the photoperiod, particularly during long days [27]. Seasonal breeding is 
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determined by the duration of exposed light (i.e. the length of days), dividing the 
estrous cycle into four phases: spring transition period, ovulatory/breeding period, 
autumn transition period, and winter anestrus.  
 The increased exposure of light during the transition from winter to spring 
marks the end of winter anestrus and the beginning of the spring transition period, 
which will last approximately 2 months. The mare’s pineal gland is stimulated by the 
release of serotonin due to nerve impulses generated from light captured by 
photoreceptors on the retina [27]. Increased exposure to light during spring and 
summer leads to a decrease in melatonin production, signaling the release of GnRH 
from the hypothalamus to the adenohyphosis, most commonly referred to as the 
anterior pituitary; here, FSH and LH are produced and then discharged to the ovaries 
[27, 29]. During this period FSH levels dominate and the production of LH, inhibin, 
insulin-like growth factor, and estradiol-17β (E2) are deficient, preventing the 
formation of preovulatory follicles [27]. Inhibin, and E2 work together to induce 
negative feedback on FSH; however, in low concentrations, negative feedback is 
inhibited, allowing FSH to remain in high concentrations. Due to the lack of LH 
synthesis, there is no production of a dominant follicle, resulting in the simultaneous 
regression of the minor follicular waves. Minor follicular waves are only produced 
during the spring transition period, with many non-ovulatory follicles developed, 
ranging from 6-21 mm in diameter [27].   
 The estrous cycle of a mare is defined as the period between two consecutive 
ovulations; this lasts approximately 18-22 days. Unlike other mammals, the mare’s 
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estrous cycle is divided into two stages: estrus (follicular phase) and diestrus (luteal 
phase) [27].  During the follicular phase, estrogen, luteinizing hormone, and inhibin 
levels peak, whereas, progesterone, FSH, and prostaglandin F2 (PGF2) levels remain 
at baseline levels (Figure B2). Estrus refers to the period in which the mare is in ‘heat,’ 
meaning she is sexually receptive to the stallion’s genitals and is ready to receive and 
transport sperm for fertilization of the oocyte. Estrus lasts approximately 5-7 days, and 
the rise in estrogen- in particular, the peak at around day 5- influences sexual behavior 
in the mare [27]. As mentioned previously, the increasing levels of inhibin and 
luteinizing hormones, which peak between days 5-7 of estrus, are responsible for 
deviation of the dominant follicle and atresia of subordinate follicles. Once deviation 
of a dominant follicle reaches completion, ovulation occurs and estrogen levels return 
to baseline while progesterone levels rise, marking the beginning of diestrus [27]. Once 
the dominant follicle ruptures and releases the mature oocyte, estrogen levels rise to 
the same level as that of progesterone, to aid in formation and maturation of the 
corpus luteum, which functions in the same ways as that of the human female. In the 
absence of implantation, the corpus luteum regresses and menstruation occurs in the 
final days of diestrus [27]. Mare menstruation differs from that in human females as 
mares do not bleed during this period. Instead, they absorb their endometrial slough 
and may also excrete it, which is advantageous to mares as bleeding may attract 
predators [29].  
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2.2.4 The Uterus, Placenta, Vagina, and Microbiota: Implications in Pregnancy 
 The uterus has one major responsibility: to provide a suitable, secure 
environment for a fetus throughout development until delivery, usually 37-40 weeks 
of gestation for humans and 320-340 days of gestation for mares [29, 30]. For human 
females, the uterus is prepared throughout menstruation for implantation of an 
embryo by increasing the thickness of the endometrial layer [20]. If implantation is 
successful, the thick endometrium will remain until after delivery and the placenta will 
Figure B2. The Mare Estrous Cycle. Divided into two phases: estrus and diestrus. Estrus occurs 
between day 1-7 and is characterized by secondary follicular waves up until the deviation of a 
dominant follicle. During this period, estrogen levels are high and progesterone is low. Ovulation 
marks the beginning of diestrus, in which progesterone levels rise and will continue to remain 
high until the corpus luteum regress (around day 13), while estrogen returns to baseline. In the 
final days of diestrus, primary follicular waves occur and estrogen slow increases as 
progesterone decreases Source(s): Journal of Steroids & Hormonal Science 2013). Source: Saute, 
K. & Gardon, J. C. A review of the estrous cycle and the neuroendocrine mechanisms in the 
mare. J Steroids Horm Sci 4(115), 1-8, doi:10.4172/2157-7536.1000115 (2013). 
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begin to develop [20]. The placenta is a temporary organ made up of both maternal 
and fetal tissues, derived from maternal endometrium and the fetal chorionic sac [31]. 
Chorion cells within the placenta will produce hCG and other luteotropins to allow the 
corpus luteum to remain [20, 31]. By maintaining the luteal gland, estrogen and 
progesterone will continue production and prevent degeneration of the endometrium 
[31]. 
The placenta functions as the region for nutrient and gas exchange between 
mother and fetus, while also providing blood supply to fetal circulation [31]. The 
function of nutrient and gas exchange is carried out by syncytium, a fused 
multinucleate trophoblast layer on the surface of the villi within the intervillous space 
[32]. The syncytium is also responsible for protecting the fetus from blood-borne 
pathogens, though how it does so is poorly understand [32]. It is important to note 
that this structure, the syncytium, is present in human females; however, placental 
structure varies greatly between mammals. Although the placenta of pregnant mares 
is diffuse and cotyledonary like that of human females, the presence of syncytium has 
not been reported [33, 34]. In a non-pregnant woman, the cervical canal acts in 
conjunction with the uterine peristaltic pump for sperm transport [35]. During 
pregnancy the cervical mucus plug forms, which acts as a permeability barrier to limit 
passage of potentially pathogenic bacteria from the vagina [35, 36]. Recent studies 
have indicated that the cervical mucus plug may not be completely impermeable to 
ascending bacteria from the vagina and, with help from the uterine peristaltic pump, 
may allow transport of bacteria into the intrauterine cavity [35, 36].  
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 Until recently, it was thought that the upper female reproductive tract did not 
possess a microbiome; however, we now know that one component, the uterus, does. 
Studies that have subjected endometrial tissue isolates to 16S rRNA gene sequencing 
in women with and/or without uterine abnormalities have identified distinct microbial 
communities [37, 38]. Verstraelen et al. harvested endometrial tissue and mucus of 
nineteen women without uterine abnormalities [37]. They targeted the 16S rRNA gene 
hypervariable V1-2 region by barcoded Illumina MiSeq paired-end sequencing and 
found 15 bacterial phyla that were present in all samples. Furthermore, it has been 
shown that this uterine microbiome persists during pregnancy [30]. These findings 
have led the field of microbiome research to question the widely accepted sterile 
womb hypothesis, which holds that the fetus develops within a sterile amnion. To 
ascertain that the amnion is sterile is also to assume that the placenta is naturally free 
of microbes and that microbes present within placental structures occur as a result of 
infection. An additional assumption of this hypothesis is that the fetus will not be 
exposed to maternal microbiota until passage through the birth canal [30]. 
 These ideas have been challenged, however, since 1927, when Harris and 
Brown discovered bacteria in the amniotic fluid of cesarean section deliveries. This 
discovery provided strong evidence that vaginal deliveries may not be the newborn’s 
initial exposure to microbes [30]. Doyle et. al conducted a study in 2014, in which they 
determined that microbial communities were present in placental membranes 
regardless of mode of delivery [39]. In addition, the authors correlated certain 
microbial communities with pre-term births and others with full-term births. This study 
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revealed a greater relative abundance of the Enterobacteriaceae family and the genera 
Fusobacterium, Streptococcus, Mycoplasma, Aerococcus, Gardnerella, and Ureaplasma 
in the pre-term samples, most of which are found in the vaginal microbiota of 
individuals with bacterial vaginosis. It was also noted that these communities were 
absent in the full term (FT) placentas. Furthermore, they discovered that bacteria were 
present in all placentas of both vaginal and caesarean births, supporting the idea that 
the fetus is exposed to microbiota prior to delivery [39]. Doyle et. al describes that 
labor is initiated by a scheduled inflammatory response in both the placenta and 
amniotic fluid, which is influenced by maternal and fetal signals. Based on this 
description, an unscheduled inflammatory response is defined as pre-term birth (PTB) 
initiation [39].  
 PTB can be classified as either very pre-term (V-PTB) or just pre-term. V-PTB, 
for humans, is defined as delivery prior to/at 28-weeks gestation and PTB is defined as 
delivery between 28-32 weeks gestation [30]. For mares, PTB is defined as delivery 
prior to 320 days gestation [34]. A common cause of PTB is infection, either exogenous 
or endogenous, which is subsequently able to pass the placental membrane and infect 
the fetus [30]. In fact, 90% of PTB cases in mammals are due to an infectious agent that 
causes severe inflammation of the placenta and amniotic fluid (placentitis and 
amnionitis) [30, 39]. In 2013, Stout et. al hypothesized that negative pregnancy 
outcomes may arise from bacterial communities residing in the maternal basal plate of 
the placenta. The results revealed Gram positive and negative intracellular bacteria in 
27% of placental basal plates with a significant association in pre-term births [40]. 
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However, bacterial communities residing in the placenta may not always be indicative 
of placentitis. A study conducted by Queiros da Mota et al. observed that 28 out of 73 
culture-positive placenta samples were positive in the presence of chorioamnionitis 
(intra-amniotic infection) and the remaining 45 cases did not, indicating that microbial 
communities in the placenta are less likely a consequence of an infectious agent and 
that microbiota may naturally transfer to the placenta during pregnancy to perform 
beneficial functions [41]. Aagaard et al. characterized 320 placental microbiome 
samples of healthy pregnancies and found that the most common microbes are 
Firmicutes, Tenericutes, Proteobacteria, Bacteroides, and Fusobacteria [42]. The 
results imply that the placenta might possess microbiota that are transient colonizers 
and that bacteria within the placenta may not always lead to negative pregnancy 
outcomes.  
 In contrast to the sterile womb hypothesis, Perez-Munoz et al. proposed that 
the infant gut microbiome is established in utero via hematogenous transfer of 
maternal oral and gut microbiota [43]. The sterile womb hypothesis argues that the gut 
microbiome of vaginally delivered babies resembles the maternal vaginal microbiome 
and C-section babies have gut microbiota similar to that of the maternal skin 
microbiota. In contrast, the in-utero colonization hypothesis states that maternal oral 
and gut microbes hematogenously transfer to the placenta throughout gestation. 
These microbes are subsequently transferred to the fetus via the umbilical cord, where 
they will begin initial colonization before birth [43]. This proposal was derived from 
results of studies in which microbiota found in placental membranes and amniotic fluid 
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were also found in the oral cavity and colon, some of which had no associated 
pregnancy complications and others linked with negative pregnancy outcomes such as 
PTB and miscarriage [44-46]. 
To investigate how the microbiome of the uterus impacts health of 
pregnancies, Moore et. al compared uterus samples of virgin and pregnant heifers 
[47]. In uteri of both virgin and pregnant heifers, three phyla were found in similar 
abundance: Bacteroidetes, Firmicutes, and Proteobacteria, which also happen to be 
common phyla of the GI tract across a majority of mammalian species. In addition, the 
investigators discovered that the same microbes present in the virgin and pregnant 
uteri are also microbes associated with post-partum uterine disease, a common cause 
of infertility in cattle due to pathogenic bacteria persisting in the uterus after delivery. 
Based on these results, Moore et. al hypothesized that post-partum uterine disease is 
most likely a result of the overgrowth of resident microbes upon pregnancy and the 
heifers’ immune response to the overgrowth. Overall, Moore et. al concluded that a 
resident microbiome of the uterus is established by the time of reproductive maturity 
[47]. Consistent with this study and several others, microbial communities found in the 
uterus are also present in the vagina and gut. Therefore, Moore et al. proposed that 
microbiota from the vagina and cervix migrate via intrauterine ascension, where they 
will subsequently colonize the uterus. The investigators also concluded that the 
uterine microbiome is maintained in a quiescent state in the virgin and pregnant 
uterus until influenced by events, in which mechanisms utilized by the body to 
maintain microbiota composition are disrupted [47]. The results of this study suggest 
30 
that negative pregnancy outcomes may be a result of the loss of ability for the host to 
keep resident microbiota under controlled growth.   
Much of the literature that encompasses uterine microbiome studies also focus 
on the vaginal microbiome of only pregnant subjects, non-pregnant subjects, or both. 
Due to discoveries of similarities between the uterine and vaginal microbiome, it 
stands to reason that microbes present in the vagina should be considered when 
investigating the microbiome’s influence on the uterus and pregnancy. This is 
especially true when considering the vertical ascension route of vaginal microbiota to 
the uterus during sexual maturity and/or to the amnion during pregnancy. A general 
consensus among vaginal microbiome studies is that, in comparison to the GI tract, the 
vagina is low in biodiversity in terms of both alpha- and beta diversity [48, 49]. These 
studies are also in agreement that a healthy vaginal microbiome is comprised mostly 
of Lactobacillus (approximately 20 species reported) and is dominated by one to two 
of the four most common Lactobacilli species: L. crispatus, L. gasseri, L. iners, and L. 
jensenii [49, 50]. It is hypothesized that Lactobacilli protect the vagina from 
colonization by pathogenic microorganisms through the production of lactic acid, and 
by outcompeting them for nutrients and epithelial cell receptors [49]. There are 
circumstances, such as bacterial vaginosis (a polymicrobial disease due to bacterial 
overgrowth in the vagina) and the variation of vaginal microbiota composition in 
women of different geographical locations, in which Lactobacilli are in smaller 
abundance and anaerobic bacteria dominate [49]. The most common anaerobes 
reported under these circumstances are Prevotella, Megasphaera, Gardnerella 
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vaginalis, Sneathia, and Atopbium vaginae. Nevertheless, composition of vaginal 
microbiota is subject to change, depending on hormonal changes, age, sexual activity, 
and overall reproductive health [49, 50]. 
 Once pregnancy is established, it is observed that the individual’s vaginal 
microbiome composition is more stable and less diverse [49]. This is primarily 
attributed to the dominance of estrogen; therefore, hormone fluctuation is 
dramatically decreased [51, 52]. It is also noted that the presence of anaerobes in the 
vagina decrease during the time of gestation. The rise of estrogen may favor 
Lactobacilli survival as this results in increased vaginal glycogen deposition [49]. 
Though the vaginal microbiome composition tends to remain constant throughout 
pregnancy, as mentioned previously, the gut microbiome changes frequently, 
independent of diet. The most commonly reported bacterial species colonizing the 
vagina in association with PTB deliveries are Ureaplasma urealyticum, Mycoplasma 
hominis, Bacteroides spp., Gardnerella vaginalis, and Fusobacterium nucleatum [49, 
50]. As mentioned previously, defects in the cervical mucus plug play a key role in the 
intrauterine ascension of vaginal bacteria. 
 After reviewing the literature, we are left with three main questions regarding 
the uterine microbiome: (1) Is the amnion exposed to microbiota? If so, in what stage 
of pregnancy is this exposure initiated and why? (2) Why and how does the host 
maintain a resident uterine microbiome upon pregnancy? (3) How do these resident 
microbes benefit the host prior to reproduction, and what is their influence on both 
mother and fetus during pregnancy? The host-microbe interactions with female 
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reproductive organs is still far from understood; additional studies are required to 
confirm that the uterus houses its own unique microbiota, as well as what this implies 
with pregnancy and female reproductive health. 
2.2.5 Objectives of Study  
Although associations have been established between microbiota and 
pregnancy outcomes, what is left to understand about how microbiota effects 
pregnancy greatly outweighs what is known to date. The objective of this study is to 
investigate the intrinsic differences between the oral and reproductive microbial 
environments of post parturient mares who either foaled at or before full term. In 
addition, we seek to further understand the relationship between microbiota and 
pregnancy outcomes, more specifically, pre-term birth. We hypothesized that either a 
lack or large abundance of a particular phylum/phyla of bacteria in the uterus will be 
observed in the mares of our equine model who deliver pre-term. Furthermore, we 
assume that this lack/presence of microbiota associated with pre-term births will 
either not be present or present in small quantities of the uteri in mares who deliver at 
full-term. 
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CHAPTER 3 
EXPERIMENTAL METHODS 
 
3.1.1 Equine Model and Sample Collection 
 Surveys were conducted of 58 post parturient (after labor) mares, and their 
foals, by attending equine veterinarians from the Hagyard Equine Medical Institute in 
Lexington, KY. These surveys included the following information about the mare: name 
of mare, date of sample collection, farm in which mare was housed, veterinarian 
obtaining samples, date of mare foaling, original expected due date, inquiry of any 
antimicrobial treatment within the last month of gestation, location of foaling, and 
circumstances of foaling (normal or dystocia and how dystocia was resolved, if 
applicable). The following information was gathered about the foal: alive or dead at 
birth, whether resuscitation or similar emergency treatment was required at time of 
birth, a list of any congenital abnormalities present, presence and severity of flexure 
tendon contracture, and a list of other abnormalities present at birth or within the first 
24-48 hours. These questions provide sufficient information as to the conditions of the 
mare and her foal pre- and post-delivery, which can be used for correlation purposes 
during data analysis. The following samples were collected from the mare by the 
attending veterinarian within 24-36 hours of foaling and before uterine 
lavage/infusion: swab from uterus or cervix, swab from vaginal vault, 2-5 ml of uterine 
fluid, blood sample, fecal sample, and oral swab. Upon collection, the samples were 
placed in biohazard bags and transported on ice to the Hagyard Laboratory, and 
34 
eventually shipped for sequencing preparation to the Oakley Laboratory at Eastern 
Kentucky University in the Department of Biological Sciences.  
3.1.2 Sample Preparation and Sequencing 
 Once samples were received, they were stored in -20°C and -80°C (dependent 
on available storage room in either unit). Samples were then organized in order by 
their corresponding survey. Each mare was labeled consecutively “Sample #” on 
biohazard bag, survey, and appropriate preparation tubes for simplicity. A table and 
key were created throughout preparation to ensure proper labeling and identifying 
which, if any, specific samples from each mare were not collected at Hagyard for data 
analysis for future additional projects. The key is described as follows: B (blood), US 
(uterine swab), OS (oral swab), VS (vaginal swab), UF (uterine fluid), and FM (fecal 
matter). An ‘X’ was placed under any column in which a sample was not present for 
that mare. All microbiome samples were labeled in consecutive numerical order (1-
332) on preparation tubes and in the table next to the appropriate mare’s name.  
 Microbiome samples were thawed at room temperature for 30 min-1 hr, 
depending on severity of frozen state. Sterile microcentrifuge tubes were labeled 
appropriately to sample information in the collection table. All collected swabs (oral, 
uterine, and vaginal) were aseptically transferred directly from collection tube to 
preparation tube. Blood samples were centrifuged for 5 minutes at 1,300 xg and a 
subsequent aliquot of 300μl was placed in the corresponding preparation tube, 
followed by a sterile nasopharyngeal swab.  
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 The aliquot and swab procedure was repeated for the uterine fluid collection, 
but these samples were not centrifuged. The aliquot was to serve as a backup in the 
event that the amount on the swab was not sufficient for sequencing. Finally, the fecal 
collection was prepared last as it takes the longest to thaw and needs to be thawed 
completely. Since the external regions of the fecal collection most likely contains 
microorganisms that are not present in the mare’s gastrointestinal tract, the collection 
was split open and a nasopharyngeal swab was scraped to the inside of the fecal 
matter. An additional small amount of the solid sample was isolated using sterile, 
disposable tweezers was placed in the preparation tube with the swab, for the same 
reason for the fluid aliquots. All prepared samples were stored at -20°C and shipped on 
dry ice to the Gilbert Laboratory in Chicago, IL for Illumina MiSeq 16S rRNA gene 
sequencing.  
3.1.3 Data Analysis 
 All data analysis of microbiome MiSeq files was executed through QIIME 1.9 on 
VirtualBox. Sequence reads were quality filtered (0.5 max errors and 151 trunclen), 
dereplicated, filtered of singletons, OTU clustered, filtered of chimeras, and mapped to 
OTUs using drive5 usearch 8.1. Greengenes database was used to assign taxonomy and 
align sequences with 97% identity. Samples exhibiting counts of ≤ 1.0 
sequence/sample was filtered from OTU tables prior to taxa summary. Relative 
abundance of taxa was reported in percentages by the summarize_taxa.py python 
script in QIIME, which calculates relative abundance by dividing the counts in a 
particular OTU by the total number of sequences observed in the sample. Alpha 
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diversity nonparametric t-distribution based on 999 Monte Carlo permutations, at a 
depth of 180 sequences/sample was executed on the final biom files, as 180 was the 
minimum number of counts observed. The Shannon diversity index metric used to 
assess alpha diversity. Jack-knifed beta diversity at an even 100 replicates was 
executed on final biom files for weighted UniFrac distance matrices, which were used 
to make Emperor PCoA plots. Significance for relative abundance of summarized taxa 
reported by QIIME was assessed with a Linear Discriminant Analysis (LDA) using LEfSe 
(LDA Effect Size), developed by the Huttenhower Lab at Harvard University, on the 
web server Galaxy.  
 
 
 
 
 
 
 
 
 
 
 
 
 
37 
CHAPTER 4 
RESULTS 
 
Illumina Miseq output analysis in QIIME reported 2,634,820 sequencing reads, 
with the maximum number of OTU counts in a given sample being 24,531. Figure 1 
shows relative abundance of a phyla summary across all sample types. A greater 
prevalence, in similar amounts, of Fusobacteria is detected in vaginal, uterine swab, 
and uterine fluid samples in comparison to the others (4.9%, 8.6%, and 8.2%, 
respectively). Figure 2 shows the same phyla summary categorized by term, showing 
an increase in Fusobacteria in PT samples in comparison to FT samples (6.1% vs 3.1%). 
To investigate the relationship between PT samples and increased Fusobacteria 
prevalence, genus summaries and corresponding proportions were produced for each 
sample type and term (Figures 3-8). PT uterine swabs share 12 genera with PT vaginal 
swabs (Figure 9), 12 genera with PT uterine fluid samples (Figure 10), 7 genera with PT 
oral swabs (Figure 11), 10 genera with PT blood samples (Figure 12), and 3 genera with 
PT fecal samples (Figure 13). FT uterine swabs share 14 genera with FT vaginal swabs 
(Figure 9), 14 genera with FT uterine fluid samples (Figure 10), 8 genera with oral 
swabs (Figure 11), 9 genera with FT blood samples (Figure 12), and 2 genera with FT 
fecal samples (Figure 13).  
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Alpha diversity was assessed by the Shannon Diversity Index for consistency 
purposes to ensure that the diversity reported in each sample is consistent with that of 
the literature. Diversity is highest within cecum and blood samples, and lower in the 
remaining sample types (Figure 14). P < 0.05 (fecal and blood vs uterine fluid, vaginal, 
oral, and uterine swabs), P > 0.05 (fecal vs blood), and P = 1.0 (oral swabs vs. uterine 
fluid, vaginal, and uterine swab samples). Weighted jackknifed beta diversity at an 
even 100 replicates is represented in PCoA plots by sample type and term (Figures 15 
and 16). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 14. Shannon Diversity Index by Sample Type. Diversity (abundance and evenness) is highest 
within the fecal and blood samples. Diversity within oral swabs are not significantly different from 
that of uterine fluid, vaginal swabs, and uterine swabs. P-values for fecal samples= 0.015 against 
uterine fluid, vaginal, oral, and uterine swabs; 0.09 against blood samples. P-values for blood= 0.015 
against uterine fluid, vaginal, oral, and uterine swabs. P-values for oral swabs= 1.0 against uterine 
fluid, vaginal, and uterine swab samples.  
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Figure 15. PCoA Plot Representation of Weighted Jackknifed Beta 
Diversity by Sample Type. Fecal samples have greater variance 
(diversity) of OTUs but fewer OTUs are shared between other sample 
types. Vaginal, uterine, and uterine fluid samples exhibit a clustering 
pattern (shared OTU abundance) as variance within these samples 
increases. Oral swabs and blood have lower variance but share OTUs 
with all other sample types.  
Figure 16. PCoA Plot Representation of Weighted Jackknifed Beta 
Diversity by Term. The same clustering patterns as seen in Figure 5, 
represented by term. The middle of the plot is representative of FT 
and PT points (OTUs) that have differing variance and do not exhibit a 
strong clustering pattern. The points are primarily vaginal, uterine 
scrape, and uterine fluid (refer to Figure 15). 
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LEfSe reported significantly abundant genus between FT and PT uterine swab 
samples (Figure 17). Significant abundant features reported for PT uterine swab: 
Fusobacterium, Gemella, Unassigned (genus designated as ‘Other’), Granulicatella, 
Geothrix, RFN20, 41B, RF16, Exiguobacterium, Actinomycetales order (genus 
unknown), Peptostreptococcus, Desulfovibrio, Mobiluncus, Cyanobacteria phylum 
(genus designated as ‘Other’), Clostridiales order (genus designated as ‘Other’), and 
Rhodocyclaceae family. Assigned approximate LDA scores for each feature is as follows 
(respective to reported PT list): 4.5, 3.7, 3.7, 3.5, 3.5, 3.3, 3.2, 3.2, 3.1, 3.0, 2.9, 2.8, 2.7, 
2.7, and 2.6. Significant abundant features reported for FT uterine swab: 
Lachnospiraceae family (genus designated as ‘Other’), Rhizobiaceae family, 
Lachnospiraceae family (genus unknown), and Rathyibacter. Assigned approximate 
LDA scores for each feature is as follows (respective to reported FT list): 2.5, 2.6, 2.7, 
and 3.5. Note that Figure 17 shows negative values for the assigned LDA scores for FT 
abundance. This is because of the order of the numerator and denominator, which is 
determined alphabetically, when calculating effect size; therefore, absolute values can 
be used when interpreting the scale of the logarithmic LDA score.   
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CHAPTER 5 
DISCUSSION 
 
5.1.1 Discussion Overview 
 Composition and proportion of bacteria detected in uterine swab and uterine 
fluid samples strongly overlaps with vaginal swab samples, supporting the vertical 
ascension route of vaginal microbiota through the cervix and to the uterus. A 
noticeable increase in prevalence of the phylum Fusobacteria is observed in uterine 
swab, uterine fluid, and vaginal samples, as well as in PT samples versus FT samples. 
Further assessment of this difference on a genus level reveals the highest abundance 
of Fusobacterium in uterine swab, vaginal swab, and uterine fluid PT samples. 
Interestingly, an inverse relationship is observed between the abundance of 
Clostridium and Fusobacterium. For instance, in FT uterine swab samples, Clostridium 
makes up approximately 8.41% of the overall genus composition, while Fusobacterium 
comprises approximately 1.6%. Meanwhile, in PT uterine swab samples, Clostridium is 
detected to be at less than 0.5%, explaining why there is not a designated spot for it on 
the pie chart; however, Fusobacterium was calculated to make up approximately 
14.48% of the overall composition. A similar trend is seen in FT/PT uterine fluid and 
vaginal swab samples. In previous studies, Clostridium is typically associated with 
negative pregnancy outcomes such as pre-term birth or even fetal death, across 
several models (human, swine, mice, etc.). In this study, it appears that Clostridium 
may provide a protective effect by outcompeting pathogenic microbes, such as 
Fusobacterium, unintentionally keeping the growth of these organisms in check.  
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Hematogenous transfer of organisms from other body sites, across the 
placenta, cannot be completely ruled out in this study. Although uterine swab samples 
shared fewer groups with blood samples (approximately 10), the genus Gemella is only 
detected in PT uterine swab, uterine fluid, blood, and oral swab samples with greatest 
abundance in the oral swabs (23.5%). It is important to note that the causative agents 
of periodontal disease that have also been isolated in the placenta, reside in the 
subgingival spaces of the mouth. In this study, those microbes were likely not isolated 
due to method of sample collection. The oral swab collection consisted of a swab of 
the buccal regions, not between the subgingival spaces. Therefore, it is possible that 
Gemella sp. in the oral cavity, and even the Fusobacterium sp. detected in the uterine 
swab/fluid samples, transferred via blood vessels in the gums and across the placental 
membrane. The only genus that was detected in the PT uterine swab samples that was 
not shared/detected with any other sample type was Granulicatella at a small relative 
abundance of 1.75%.  
 An LDA reported markedly different results than the relative abundance 
reports. According to this analysis, Clostridium is not significantly abundant in FT 
uterine swab samples over PT uterine swab samples, and several taxa are reported to 
be significant in PT uterine swab samples that were not reported in the relative 
abundance charts. What is consistent between the reported LDA of summarized taxa 
and relative abundance is the abundance of Fusobacterium, Gemella, and 
Granulicatella being significantly more abundant in PT uterine swab samples compared 
to FT, with the largest score assigned to Fusobacterium, consistent with the reported 
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relative abundance. Clostridium, Fusobacterium, Gemella, and Granulicatella will be 
described throughout the remainder of this chapter to assess mechanisms behind how 
these microorganisms influence pregnancy outcomes. Furthermore, possible 
explanations will be explored for why Fusobacterium was reported at low relative 
abundance in the oral genus summaries.  
5.1.2 Fusobacterium: Mechanisms of Pathogenesis  
 The phylum Fusobacteria consists of a group of gram-negative, non-spore 
forming, obligate anaerobes that typically inhabit the oral cavity as a commensal; in 
fact, Fusobacteria species are one of the most frequently detected bacteria in both 
healthy and diseased oral cavities [53, 54]. Furthermore, the genus Fusobacterium is 
the second most recurrently isolated anaerobic bacteria in human and animal 
microbiota [55]. Fusobacteria, more specifically Fusobacterium nucleatum, has been 
identified as a causative agent of most periodontal disease cases and has been 
associated with negative pregnancy outcomes (still birth, preterm birth, spontaneous 
abortion, and early-onset neonatal sepsis), GI disorders, skin ulcers, Lemierre’s 
syndrome, etc. [53-58]. F. nucleatum is the most commonly identified Fusobacterium 
sp. in a wide variety of diseases due to the virulence factors it possesses. F. nucleatum 
has the abilities to coaggregate with other species to enhance disease progression and 
invade a variety of mammalian cells and host molecules via adhesins [53-55]. Adhesins 
are surface proteins that function in the attachment of bacterial cells to specific host-
cell receptors/substrates or, in some cases of F. nucleatum pathogenesis, to salivary 
macromolecules, immunoglobulin G, and extracellular matrix proteins [53, 55]. F. 
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nucleatum has a tropism for several cell types including epithelial and endothelial cells, 
polymorphonuclear leukocytes, natural killer (NK) cells, erythrocytes, fibroblasts, and 
monocytes [53, 55]. 
 F. nucleatum’s ability to coaggregate with other bacteria is one of the reasons 
why it is often detected in mixed-community infections [55]. It does so by recognizing 
surface molecules on other species either by adhesins (Fap2, RadD, and aid1) or other 
outer membrane proteins (OMPs) [53, 54]. Coaggregation of F. nucleatum with other 
species of bacteria is the key first step to plaque formation in the oral cavity, usually in 
the subgingival spaces. The adhesin and invasin identified as FadA is the most well-
studied F. nucleatum virulence factor [59]. FadA becomes an active complex (FadAc) 
when its two forms bind to one another, intact pre-FadA and secreted mature FadA 
(mFadA), of which is an absolute requirement for F. nucleatum to bind to and invade 
host cells [53]. FadAc attaches to cadherins, which are calcium-dependent adhesion 
molecules responsible for forming adherens junctions to bind host cells together [59].  
Another well-studied virulence factor of F. nucleatum is Fap2, abbreviated for 
fusobacterial apoptosis protein [54]. In a 2015 study conducted by Coppenhagen-
Glazer et. al, the authors characterized Fap2 as a galactose-inhibitable adhesin after 
observing the inhibition of hemagglutination (a mode of attachment conserved across 
many pathogens) in a strain of F. nucleatum by the addition of D-galactose, showing 
that Fap2 is galactose-sensitive/inhibitable. Furthermore, Coppenhagen-Glazer et. al 
discovered that Fap2 also plays a role in coaggregation after noting that three 
hemagglutination-deficient mutant F. nucleatum strains failed to coaggregate with 
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Porphyromonas gingivalis but retained coaggregation ability with Streptococcus 
sanguins. To observe the role of Fap2 in placental colonization of F. nucleatum, since 
FadA had been previously described as the only major virulence factor in adverse 
pregnancy outcomes, the investigators injected wild-type F. nucleatum and the 
hemagglutination-deficient mutant strain into the tail veins of CD1 female mice. They 
observed that the Fap2 mutant strain reduced placental colonization of F. nucleatum 
2-fold [54].  
The most frequently reported method by which Fusobacterium results in 
negative pregnancy outcomes is by hematogenous transfer from the oral cavity in 
pregnant women with periodontitis [53-55]. In 2004, Han et. al studied the effects of 
dental bacteremia, induced by F. nucleatum, on pregnancy outcomes. Seventy-two 
hours after injecting F. nucleatum into the tail vein of pregnant mice, the investigators 
observed cases of preterm birth and fetal death at term [60]. In a similar study 
conducted by Stockham et. al in 2015, three aims were investigated: 1) determine if 
hematogenous transfer of F. nucleatum from the oral cavity to the murine placenta 
and subsequent adverse pregnancy outcomes is strain specific, 2) utilize an oral gavage 
murine model of periodontitis to observe if increased severity of adverse pregnancy 
outcomes is influenced by induced periodontitis, and 3) compare immunological 
changes of the induced periodontitis pregnant murine model to intravenous injection 
of different F. nucleatum subspecies and correlate these changes to any adverse 
pregnancy outcomes that arise. The authors observed that hematogenous transfer 
from the oral cavity to the placenta was strain specific as F. nucleatum was the only 
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Fusobacterium sp. that colonized the placenta. Furthermore, inducing periodontitis did 
not further increase the severity of adverse pregnancy outcomes and there were no 
significant immunological changes between pregnant control mice and pregnant 
inoculated mice [56].  
In this study, we did not observe Fusobacterium reported in relative abundance 
of PT oral swabs. but it was reported in similar abundance in PT vaginal swabs. 
Fusobacterium has been identified in cases of bacterial vaginosis and urinary tract 
infections, which can lead to negative pregnancy outcomes [61]. Interestingly, we 
observed a rather high biodiversity in all vaginal swab samples. Although, alpha 
diversity was reported as being low in vaginal swabs, several different genera were 
identified, which usually is not the case for human females. As discussed in Chapter 3, 
Lactobacillus sp. dominates the vaginal microbiome, with some variation, and remains 
dominant throughout pregnancy due to increased estrogen levels. Lactobacillus’s role 
in creating an acidic pH environment in the vagina exerts protection against obligate 
anaerobes by providing an unsuitable environment for their survival. A disruption in 
Lactobacillus dominance of the vagina is often the result of bacterial vaginosis [61]. In 
both FT and PT vaginal samples of mares, Lactobacillus does not dominate, and 
diversity appears to be high- despite the tendency of diversity in the vagina to 
decrease during pregnancy. These results, however, have been found to be true for 
humans and laboratory mice- mares live in a much different environment and have a 
vastly different diet; therefore, it is not surprising to observe a unique diversity in an 
equine model in comparison to mouse models and human studies. Due to the lack of 
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studies using equine models for microbiota characterization, we do not currently know 
what communities constitute a healthy vaginal microbiome for mares; therefore, we 
cannot definitively state which organisms are resident microbiota and which are 
pathogenic transient colonizers, as we do not have sufficient comparison. 
5.1.3 Clostridium: Mode of Competition  
 Clostridium is a Gram-positive, obligate anaerobe genus under the phylum 
Firmicutes [62]. Many Clostridium sp. are responsible for causing serious disease, such 
as Clostridium perfringens and gas gangrene, Clostridium difficile and diarrhea, 
Clostridium tetani and tetanus, Clostridium botulinum and botulism, and Clostridium 
sordellii and toxic shock syndrome in post-partum women [63-67]. On the other hand, 
several Clostridium sp. are found to be part of a normal and healthy resident 
microbiome [3]. For example, although C. difficile can create infection within the GI 
tract, it is also part of the normal gut microbiome in small abundance because other 
populations dominate and outcompete it; in fact, C. difficile infections are most 
commonly a result of antibiotic-induced gut dysbiosis [11]. Clostridium has also been 
identified as part of a normal vaginal microbiome in less than 10% of women; 
therefore, it is not entirely unusual to find Clostridium sp. in a healthy woman, 
especially since these characterizations vary geographically [5, 30].  
 Clostridium has the ability to produce antimicrobial peptides (AMPs) termed 
bacteriocins [68, 69]. Bacteriocins function to aid the bacterium secreting it in 
outcompeting other bacteria similar to it. In essence, Clostridium will sense bacteria 
that are in close proximity, of which metabolize the same nutrients as it does for 
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survival [69].  All Clostridium sp. ferment butyrate and amino acids serine and 
threonine, while others can utilize tryptophan, histidine, arginine, alanine, methionine, 
leucine, asparatate, lysine, and/or phenylalanine, suggesting that amino acid 
fermentation is strain-specific [70]. All strains of Fusobacterium ferment butyrate and 
use glutamate, histidine, and aspartate for energy metabolism. In addition, 
Fusobacterium nucleatum utilizes glutamine and lysine for anaerobic fermentation in 
order to produce sufficient energy for glucose transport in the event of intracellular 
molecule biosynthesis [55]. Here, we propose that because Clostridium and 
Fusobacterium utilize much of the same amino acids for energy metabolism, 
Clostridium could potentially secrete bacteriocins to reduce or eliminate the growth of 
Fusobacterium in the uterus of a healthy mare. When Clostridium growth is reduced, 
possibly due to a dysbiosis in the uterus, Fusobacterium is able to outcompete it, 
resulting in placentitis and amnionitis, and eventual PTB. It was noted that Clostridium 
was reported in similar proportion in the vaginal swab samples as the uterine swab 
and uterine fluid samples. Considering the intrauterine ascension route of vaginal 
microbiota, the same relationship proposed between Clostridium and Fusobacterium 
could also be occurring in the mare’s vagina.  
5.1.4: Gemella and Granulicatella:  
Gemella is a gram-positive, obligate anaerobe genus under the phylum 
Firmicutes [71]. It is a normal constituent of the oral cavity, upper GI tract, and vaginal 
microbiome in select populations [71]. Gemella is not frequently reported as cause for 
disease in clinical cases as it is primarily an opportunistic pathogen when mucosal 
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membranes are compromised, such as the lung environment in cystic fibrosis patients 
[71]. Because it has a preferred niche for mucosal areas, it is not surprising that this 
genus of bacteria was found in the uterine fluid, as this sample type is primarily a 
collection of the cervical and endometrial mucus. However, Gemella was detected in 
PT samples, but not in FT samples, suggesting that this bacterium may not be part of a 
microbiome in a healthy mare’s reproductive tract. Additionally, it is important to note 
the small relative abundance reported in the uterine fluid and uterine swab samples 
because it does not appear to be an overgrowth and therefore, may not be 
contributing to the initiation of PTB. Lastly, Granulicatella was previously designated as 
nutritionally variant streptococci (NVS), but is now described as ‘streptococci-like’ due 
to a few distinct metabolic differences [72]. This bacterium has been described as a 
mouth and urogenital tract commensal; in terms of pathogenesis, it rarely causes 
disease. Granulicatella sp. has primarily been detected as an opportunistic pathogen in 
immunocompromised patients, most commonly causing infective endocarditis in the 
elderly, and has been reported in a few pre-term birth cases of mothers diagnosed 
with urinary tract infections [72, 73]. This genus is a fastidious, Gram-positive, 
facultative anaerobe under the phylum Firmicutes [73]. Much like Gemella, 
Granulicatella was detected in small relative abundance, only in the PT uterine swab 
samples; therefore, it does not appear to be an overgrowth and is unlikely to have 
initiated infection within the pregnant uterus.  
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CHAPTER 6 
CONCLUSIONS & FUTURE DIRECTIONS 
 
6.1.1 Conclusions  
 Mares may establish a uterine microbiome from vaginal microbiota during 
sexual maturity. In the event of pregnancy, stability in the flux of microbiota 
contributes to a healthy pregnancy; however, when these communities are disrupted, 
pathogenic microorganisms are able to colonize, proliferate rapidly, and infiltrate 
other body sites. In this study, it appears that a reduction in Clostridium populations in 
the upper and lower female reproductive tract results in the overgrowth of other 
microorganisms, such as Fusobacterium sp. However, this result must be taken with 
caution and further analyzed, as a linear discriminant analysis did not report 
Clostridium abundance to be significant in FT versus PT uterine swabs. Since the 
Lachnospiraceae family (under the Clostridia class) was reported significantly abundant 
in FT uterine swab samples with the highest LDA score, it may be more accurate to 
hypothesize that Clostridia exert a protective effect in the uterus during pregnancy, 
rather than the more narrow, specific identification of the Clostridium genus.  
Due to the large increase in Fusobacterium in PT uterine swab and vaginal swab 
samples, as well as being reported as the most significantly abundant feature over FT 
uterine swabs, we conclude that this microbe is the infectious agent initiating pre-term 
birth, though the exact mechanism by which Fusobacterium initiates such an event in 
these mares is unknown. Before a correlation can be established between the 
relationship of Clostridium sp. and the female reproductive tract of mares, further 
76 
experimentation is required. We have shown here that Fusobacterium can lead to 
negative pregnancy outcomes in mares much like in humans and laboratory mouse 
models, suggesting that mechanisms of pathogenesis in this bacterium is ubiquitous 
across various mammalian species. This study provides evidence against the sterile 
womb hypothesis and contributes to the field preliminary results on the influence of 
microbiota on pregnancy outcomes in mares. We have characterized the uterine and 
vaginal microbiome in post-parturient mares, which has not been done before; 
therefore, the results of this study could prove to be useful in the prenatal care of 
pregnant mares. There is one study to date that characterized the uterine microbiome 
of non-pregnant mares, but only beta diversity is reported, of which shows a moderate 
diversity within the uterus [74]. The taxonomy of these microbes is unclear; therefore, 
we do not have any baseline comparison for our results.  
6.1.2 Future Directions  
To continue assessment of the microbiome’s influence on pregnancy outcomes 
in an equine model, the previously described methods should be repeated; however, a 
routine vaginal and oral swab collection throughout the gestational period may be a 
useful additional measure. Observing the vaginal microbiome, throughout pregnancy, 
could provide insight into the stability, or instability, of a particular mare’s vaginal 
microbial communities and may help predict pregnancy outcomes like pre-term birth. 
This is important for the field of equine care because mares that give birth pre-term 
one time, tend to carry out a habit of always delivering pre-term and the cause for this 
is unknown. Understanding the mechanisms behind this and creating diagnostic 
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measures to prevent such negative outcomes could provide a substantial boost for the 
advancement of veterinary medicine and the equine industry. Because hematogenous 
transfer of microbes has been reported in cases of pre-term birth and fetal death, 
routine oral swab and blood collection may also be a useful predictive measure in 
conjunction with routine vaginal swab assessment. The oral swab should be a 
collection from the subgingival spaces in order to isolate and identify bacteria involved 
in dental bacteremia and periodontal disease.  
 Another problem that needs to be addressed is the lack of knowledge 
pertaining to the characterization of the normal, healthy vaginal microbiome in mares. 
If possible, repetitive assessment of vaginal swab collections of healthy, non-pregnant 
mares could result in a sufficient characterization and could be used for future 
comparative analyses. Furthermore, knowing a mare’s vaginal microbiome prior to 
pregnancy, could provide insight into potential pregnancy outcomes that particular 
mare may be susceptible to, allowing for proper preventative care to be administered. 
In closing, although the results of this study are not currently generalizable to humans, 
further experimentation with the recommended additions may provide translational 
results in the future.   
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